Esophageal cancer is the sixth leading cause of cancer death in the world and carries a 5-year survival rate of only 15–25%. A brief overview of presenting signs and symptoms as well as common manifestations of disease burden is presented. Review of the American Joint Committee on Cancer (AJCC) tumor/node/metastasis (TNM) classification provides insight to imaging and workup. Ultimately, staging dictates survival. Patient factors impacting surgical candidacy greatly impact the care patients diagnosed receive. Ultimately a multidisciplinary approach directs care.
KeywordsEsophageal cancer Adenocarcinoma Squamous cell carcinoma Staging Esophagectomy Chemoradiation
- 3.Townsend C, Bouchamp DB, Evers MB, Mattox K. Sabiston textbook of surgery: the biological basis of modern surgical practice. 20th ed. Philadelphia: Elsevier; 2016.Google Scholar
- 4.Varghese TK, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, et al. The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg [Internet]. 2013;96(1):346–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23752201.CrossRefGoogle Scholar
- 7.Kidane B, Coughlin S, Vogt K, Malthaner R. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev [Internet]. 2015;(5):CD001556. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25988291.
- 8.Martin RCG, Cannon RM, Brown RE, Ellis SF, Williams S, Scoggins CR, et al. Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer. Oncologist [Internet]. 2014;19(3):259–65. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958458/.CrossRefGoogle Scholar